Align Technology [ALGN] vs West Pharmaceutical [WST] Detailed Stock Comparison

Align Technology

NASDAQ

West Pharmaceutical

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Align Technology wins in 10 metrics, West Pharmaceutical wins in 9 metrics, with 0 ties. Align Technology appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Align Technology	West Pharmaceutical	Better
P/E Ratio (TTM)	25.27	37.05	Align Technology
Price-to-Book Ratio	2.77	6.08	Align Technology
Debt-to-Equity Ratio	3.14	10.52	Align Technology
PEG Ratio	0.73	1.88	Align Technology
EV/EBITDA	12.59	22.32	Align Technology
Profit Margin (TTM)	11.04%	16.48%	West Pharmaceutical
Operating Margin (TTM)	16.10%	20.87%	West Pharmaceutical
EBITDA Margin (TTM)	16.10%	20.87%	West Pharmaceutical
Return on Equity	11.41%	17.72%	West Pharmaceutical
Return on Assets (TTM)	6.50%	10.53%	West Pharmaceutical
Free Cash Flow (TTM)	$622.65M	$276.40M	Align Technology
Dividend Yield	N/A	0.38%	N/A
1-Year Return	-36.07%	-18.14%	West Pharmaceutical
Price-to-Sales Ratio (TTM)	2.73	6.02	Align Technology
Enterprise Value	$10.06B	$17.62B	West Pharmaceutical
EV/Revenue Ratio	2.54	5.95	Align Technology
Gross Profit Margin (TTM)	69.94%	35.73%	Align Technology
Revenue per Share (TTM)	$54	$41	Align Technology
Earnings per Share (Diluted)	$5.92	$6.69	West Pharmaceutical
Beta (Stock Volatility)	1.61	1.05	West Pharmaceutical

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Align Technology vs West Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Align Technology	6.33%	5.01%	-22.93%	-13.35%	-21.58%	-28.26%
West Pharmaceutical	2.15%	0.67%	13.23%	18.88%	12.11%	-24.53%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Align Technology	-36.07%	-40.75%	-50.24%	161.17%	817.61%	2,197.54%
West Pharmaceutical	-18.14%	-18.41%	-8.74%	335.90%	1,343.51%	1,749.63%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Align Technology (ALGN): View Full Stock Overview

West Pharmaceutical (WST): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Align Technology vs West Pharmaceutical

Metric	ALGN	WST
Market Information
Market Cap i	$10.84B	$17.82B
Market Cap Category	Large cap	Large cap
10 Day Avg. Volume i	1,601,380	502,040
90 Day Avg. Volume i	2,042,050	758,013
Last Close	$149.57	$247.85
52 Week Range	$127.70 - $262.87	$187.43 - $352.33
% from 52W High	-43.10%	-29.65%
All-Time High	$737.45 (Sep 20, 2021)	$475.35 (Sep 06, 2021)
% from All-Time High	-79.72%	-47.86%
Growth Metrics
Quarterly Revenue Growth	-0.02%	0.09%
Quarterly Earnings Growth	0.29%	0.18%
Financial Health
Profit Margin (TTM) i	0.11%	0.16%
Operating Margin (TTM) i	0.16%	0.21%
Return on Equity (TTM) i	0.11%	0.18%
Debt to Equity (MRQ) i	3.14	10.52
Cash & Liquidity
Book Value per Share (MRQ)	$53.98	$40.74
Cash per Share (MRQ)	$12.43	$7.09
Operating Cash Flow (TTM) i	$731.07M	$676.70M
Levered Free Cash Flow (TTM) i	$676.43M	$207.85M
Dividends
Last 12-Month Dividend Yield i	N/A	0.38%
Last 12-Month Dividend i	N/A	$0.83

Valuation & Enterprise Metrics Analysis: Align Technology vs West Pharmaceutical

Metric	ALGN	WST
Price Ratios
P/E Ratio (TTM) i	25.27	37.05
Forward P/E i	14.58	32.96
PEG Ratio i	0.73	1.88
Price to Sales (TTM) i	2.73	6.02
Price to Book (MRQ) i	2.77	6.08
Market Capitalization
Market Capitalization i	$10.84B	$17.82B
Enterprise Value i	$10.06B	$17.62B
Enterprise Value Metrics
Enterprise to Revenue i	2.54	5.95
Enterprise to EBITDA i	12.59	22.32
Risk & Other Metrics
Beta i	1.61	1.05
Book Value per Share (MRQ) i	$53.98	$40.74

Financial Statements Comparison: Align Technology vs West Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	ALGN	WST
Revenue/Sales i	$979.26M	$766.50M
Cost of Goods Sold i	$299.15M	$492.60M
Gross Profit i	$680.11M	$273.90M
Research & Development i	$97.20M	$19.10M
Operating Income (EBIT) i	$135.28M	$158.90M
EBITDA i	$178.60M	$203.40M
Pre-Tax Income i	$140.44M	$157.00M
Income Tax i	$47.21M	$30.20M
Net Income (Profit) i	$93.23M	$131.80M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	ALGN	WST
Cash & Equivalents i	$873.01M	$509.70M
Total Current Assets i	$2.40B	$1.68B
Total Current Liabilities i	$1.99B	$604.60M
Long-Term Debt i	$86.49M	$282.40M
Total Shareholders Equity i	$3.79B	$2.93B
Retained Earnings i	$2.39B	$4.14B
Property, Plant & Equipment i	$1.38B	$3.28B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	ALGN	WST
Operating Cash Flow i	$139.21M	$177.40M
Capital Expenditures i	$-25.29M	N/A
Free Cash Flow i	$27.39M	$101.90M
Debt Repayment i	N/A	$-300,000
Common Stock Repurchase i	$-201.09M	$-500,000

Short Interest & Institutional Ownership Analysis

Metric	ALGN	WST
Shares Short i	2.74M	2.17M
Short Ratio i	1.83	2.62
Short % of Float i	0.05%	0.04%
Average Daily Volume (10 Day) i	1,601,380	502,040
Average Daily Volume (90 Day) i	2,042,050	758,013
Shares Outstanding i	73.85M	72.30M
Float Shares i	67.59M	71.41M
% Held by Insiders i	0.07%	0.01%
% Held by Institutions i	0.95%	0.98%

Dividend Analysis & Yield Comparison: Align Technology vs West Pharmaceutical

Metric	ALGN	WST
Last 12-Month Dividend i	N/A	$0.83
Last 12-Month Dividend Yield i	N/A	0.38%
3-Year Avg Annual Dividend i	N/A	$0.79
3-Year Avg Dividend Yield i	N/A	0.07%
3-Year Total Dividends i	N/A	$2.37
Ex-Dividend Date	N/A	Apr 30, 2025

Align Technology [ALGN] vs West Pharmaceutical [WST] Detailed Stock Comparison